Upstream Bio, Inc. (UPB) support and resistance · rev $2.4M
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
This page maps Upstream Bio, Inc. (UPB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
UPB currently screens at market cap $407.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new UPB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the UPB quote page for the session range and the stock page for the full model.
Not investment advice.